热门资讯> 正文
MyMD Pharma宣布将品牌更名为TNFPharmaceuticals
2024-07-22 22:52
- TNF Pharmaceuticals, formerly MyMD Pharmaceuticals, on Monday announced a rebranding to the new name “TNF Pharmaceuticals,” effective today.
- The company said it plans mid-stage clinical trials of TNF-alpha inhibitor drug MYMD-1 following statistically significant Phase 2 studies.
- The company added that it will begin trading on Nasdaq under the new trading symbol "TNFA" effective July 24, 2024.
- Press release.
More on MyMD Pharmaceuticals
- Financial information for MyMD Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。